Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Overall Mortality and LDL Cholesterol Reduction in Secondary Prevention Trials of Cardiovascular Disease.

Pedro-Botet J, López-Miranda J, Badimón L, Civeira F, Guijarro C, Millán J, Mostaza JM, Pintó X, Valdivielso P, Masana L; Expert group from the Spanish Arteriosclerosis Society.

Am J Cardiovasc Drugs. 2019 Oct 25. doi: 10.1007/s40256-019-00376-y. [Epub ahead of print] Review.

PMID:
31650523
2.

Phenotype of haptoglobin and presence of subclinical vascular disease: Population study.

Mostaza JM, de Dios O, Lahoz C, Arribas M, Pérez Arroyo A, Salinero-Fort MA, Laguna F, Estirado E, García-Iglesias F, González Alegre T, Sabín C, López S, Sánchez V, Cornejo V, Garcés C; en representación de los investigadores del estudio ESPREDIA.

Clin Investig Arterioscler. 2019 Jun 17. pii: S0214-9168(19)30050-6. doi: 10.1016/j.arteri.2019.03.007. [Epub ahead of print] English, Spanish.

PMID:
31221534
3.

A new variant (c.1A>G) in LDLRAP1 causing autosomal recessive hypercholesterolemia: Characterization of the defect and response to PCSK9 inhibition.

Rodríguez-Jiménez C, Gómez-Coronado D, Frías Vargas M, Cerrato F, Lahoz C, Saban-Ruiz J, González-Nieto D, Lasunción MA, Mostaza JM, Rodríguez-Nóvoa S.

Atherosclerosis. 2019 May;284:223-229. doi: 10.1016/j.atherosclerosis.2019.01.010. Epub 2019 Jan 25.

PMID:
30777337
4.

Prevalence of atrial fibrillation and associated anticoagulant therapy in the nonagenarian population of the Community of Madrid, Spain.

Lahoz C, Cardenas J, Salinero-Fort MÁ, Mostaza JM.

Geriatr Gerontol Int. 2019 Mar;19(3):203-207. doi: 10.1111/ggi.13587. Epub 2018 Dec 18.

PMID:
30561128
5.

COSMIC project: consensus on the objectives of the metabolic syndrome in clinic.

Pedro-Botet J, Ascaso JF, Barrios V, De la Sierra A, Escalada J, Millán J, Mostaza JM, Pérez-Martínez P, Pintó X, Salas-Salvadó J, Valdivielso P.

Diabetes Metab Syndr Obes. 2018 Oct 31;11:683-697. doi: 10.2147/DMSO.S165740. eCollection 2018. Review.

6.

Cardiovascular disease in nonagenarians: Prevalence and utilization of preventive therapies.

Mostaza JM, Lahoz C, Salinero-Fort MA, Cardenas J.

Eur J Prev Cardiol. 2019 Mar;26(4):356-364. doi: 10.1177/2047487318813723. Epub 2018 Nov 14.

PMID:
30426771
7.

R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction.

Mostaza JM, Lahoz C, Salinero-Fort MA, de Dios O, Castillo E, González-Alegre T, García-Iglesias F, Estirado E, Laguna F, Sabín C, López S, Cornejo V, de Burgos C, Sanchez V, Garcés C; investigators of the SPREDIA-2 Group.

J Clin Lipidol. 2018 Jul - Aug;12(4):1039-1046.e3. doi: 10.1016/j.jacl.2018.04.004. Epub 2018 Apr 21.

PMID:
29773421
8.

Relationship of the Adherence to a Mediterranean Diet and Its Main Components with CRP Levels in the Spanish Population.

Lahoz C, Castillo E, Mostaza JM, de Dios O, Salinero-Fort MA, González-Alegre T, García-Iglesias F, Estirado E, Laguna F, Sanchez V, Sabín C, López S, Cornejo V, de Burgos C, Garcés C; Investigators of the SPREDIA-2 Group.

Nutrients. 2018 Mar 20;10(3). pii: E379. doi: 10.3390/nu10030379.

9.

Risk factors associated with the carotid intima-media thickness and plaques: ESPREDIA Study.

Mostaza JM, Lahoz C, Salinero-Fort MA, Laguna F, Estirado E, García-Iglesias F, González Alegre T, Sabín C, López S, Cornejo V; en representación de los investigadores del estudio ESPREDIA.

Clin Investig Arterioscler. 2018 Mar - Apr;30(2):49-55. doi: 10.1016/j.arteri.2017.07.005. Epub 2017 Sep 20. English, Spanish.

PMID:
28939054
10.

Peripheral Atherosclerosis in Patients With Erectile Dysfunction: A Population-Based Study.

Lahoz C, Mostaza JM, Salinero-Fort MA, García-Iglesias F, González-Alegre T, Estirado E, Laguna F, de Burgos-Lunar C, Sánchez-Arroyo V, Sabín C, López S, Cornejo-Del-Río V, Patrón P, Fernández-García P, Fernández-Puntero B, Vicent D, Montesano-Sanchez L; SPREDIA-2 Group.

J Sex Med. 2016 Jan;13(1):63-9. doi: 10.1016/j.jsxm.2015.11.011.

PMID:
26755088
11.

Carotid atherosclerosis severity in relation to glycemic status: a cross-sectional population study.

Mostaza JM, Lahoz C, Salinero-Fort MA, de Burgos-Lunar C, Laguna F, Estirado E, García-Iglesias F, González-Alegre T, Cornejo-Del-Río V, Sabín C, López S; SPREDIA-2 Group.

Atherosclerosis. 2015 Oct;242(2):377-82. doi: 10.1016/j.atherosclerosis.2015.07.028. Epub 2015 Jul 15.

PMID:
26275375
12.

[Cancer and cardiovascular disease].

Lahoz C, Valdivielso P, González-Alegre MT, García-Iglesias MF, Estirado E, Mostaza JM.

Clin Investig Arterioscler. 2015 Sep-Oct;27(5):221-5. doi: 10.1016/j.arteri.2015.02.002. Epub 2015 Mar 12. Review. Spanish.

PMID:
25772547
13.

Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish Society of Internal Medicine.

Gómez-Huelgas R, Giner-Galvañ V, Mostaza JM, Cuende JI, de Miguel-Yanes JM, Rovira E, Sánchez-Fuentes D, Suárez Fernández C, Román Sánchez P; SEMI Working Group.

BMC Cardiovasc Disord. 2014 Dec 18;14:193. doi: 10.1186/1471-2261-14-193.

14.

[Achievement of low-density lipoprotein cholesterol therapeutic goal in lipid and vascular risk units of the Spanish Arteriosclerosis Society].

Pedro-Botet J, Mostaza JM, Pintó X, Banegas JR; En Nombre del Grupo de Investigadores EDICONDIS-ULISEA.

Clin Investig Arterioscler. 2013 Sep-Oct;25(4):155-63. doi: 10.1016/j.arteri.2013.07.006. Epub 2013 Sep 14. Spanish.

PMID:
24041476
15.

Differences in the ankle-brachial index in the general population after 4 years of follow-up.

Lahoz C, Garcia-Fernandez T, Barrionuevo M, Vicente I, Gonzalez-Alegre T, Mostaza JM.

Vasa. 2013 Mar;42(2):112-9. doi: 10.1024/0301-1526/a000254.

PMID:
23485838
16.

Prevalence and clinical characteristics of peripheral arterial disease in the study population Hermex.

Félix-Redondo FJ, Fernández-Bergés D, Grau M, Baena-Diez JM, Mostaza JM, Vila J.

Rev Esp Cardiol (Engl Ed). 2012 Aug;65(8):726-33. Epub 2012 Jun 22. English, Spanish.

PMID:
22727799
17.

Utilization of evidence-based cardiovascular therapies and achievement of therapeutic goals in patients with peripheral artery disease.

Mostaza JM, Puras E, Blasco M, Lahoz C, Samaniego ML.

Rev Esp Cardiol (Engl Ed). 2012 Aug;65(8):713-8. Epub 2012 May 31. English, Spanish.

PMID:
22658690
18.

Different prognostic value of silent peripheral artery disease in type 2 diabetic and non-diabetic subjects with stable cardiovascular disease.

Mostaza JM, Manzano L, Suarez C, Fernandez C, García de Enterría MM, Tirado R, Nicolás F, Sanchez-Zamorano MA.

Atherosclerosis. 2011 Jan;214(1):191-5. doi: 10.1016/j.atherosclerosis.2010.10.020. Epub 2010 Oct 28.

PMID:
21075374
19.

A comparative study of biomarkers for risk prediction in acute coronary syndrome-Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study.

Kaski JC, Fernández-Bergés DJ, Consuegra-Sánchez L, Fernández JM, García-Moll X, Mostaza JM, Cebada RT, Juanatey JR, Martínez GG, Marrugat J.

Atherosclerosis. 2010 Oct;212(2):636-43. doi: 10.1016/j.atherosclerosis.2010.06.026. Epub 2010 Jun 19.

PMID:
20619836
20.

[HDL-cholesterol: from risk factor to therapeutic target].

Lahoz C, Mostaza JM.

Med Clin (Barc). 2009 Jul 11;133(6):229-34. doi: 10.1016/j.medcli.2008.10.034. Epub 2009 Jun 16. Review. Spanish.

PMID:
19535113

Supplemental Content

Loading ...
Support Center